Gracell Biotechnologies Inc. American Depositary Shares
GRCL
GRCL was delisted on the 21st of February, 2024.
32 hedge funds and large institutions have $270M invested in Gracell Biotechnologies Inc. American Depositary Shares in 2021 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 11 closing their positions.
0.1% less ownership
Funds ownership: 30.86% → 30.76% (-0.1%)
11% less funds holding
Funds holding: 36 → 32 (-4)
16% less capital invested
Capital invested by funds: $321M → $270M (-$50.8M)
20% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 10
36% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 11
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$9.5M |
| 2 |
CCM
CloudAlpha Capital Management
Hong Kong
|
+$3.88M |
| 3 |
CII
Capital International Inc
Los Angeles,
California
|
+$1.53M |
| 4 |
Morgan Stanley
New York
|
+$1.48M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$285K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$6.16M |
| 2 |
VC
Vivo Capital
Palo Alto,
California
|
-$2.61M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.04M |
| 4 |
BCIMC
Boyu Capital Investment Management Company
Hong Kong
|
-$1.97M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$1.93M |
GRCL Hedge Fund Activity: Q2 2021 in Review
32 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Gracell Biotechnologies Inc. American Depositary Shares (GRCL) for Q2 2021, worth a combined $270M — down 16% from $321M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of GRCL and 7 opened new positions — a net loss of 4 holders — while 10 trimmed existing stakes and 8 added.
The largest buyer was Wellington Management Group, adding an estimated $9.5M. The largest seller was Deerfield Management, exiting entirely with an estimated $6.16M sold.
- 32 institutional investors held Gracell Biotechnologies Inc. American Depositary Shares (GRCL) as of Q2 2021, down from 36 in Q1 2021.
- Funds reported $270M of Gracell Biotechnologies Inc. American Depositary Shares stock for Q2 2021, down 16% quarter-over-quarter.
- 7 funds opened new Gracell Biotechnologies Inc. American Depositary Shares positions in Q2 2021 and 11 closed out, a net change of -4 holders.
- The largest Gracell Biotechnologies Inc. American Depositary Shares buyer in Q2 2021 was Wellington Management Group, an estimated $9.5M added.
- The largest Gracell Biotechnologies Inc. American Depositary Shares seller in Q2 2021 was Deerfield Management, an estimated $6.16M sold.
Based on aggregated 13F filings for Q2 2021.